Cancer
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 27, 2024
FDA Approves Selpercatinib for RET Fusion–Positive Medullary Thyroid Cancer
The ASCO Post
September 26, 2024
More Than Half of AYA Cancer Survivors Experience Financial Toxicity and Are Unable to Afford Food and Housing
The ASCO Post
Advertisement
Recommendations
Advertisement